Clinical Trial Update: Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on Cadonilimab in combination with liposomal irinotecan, leucovorin, and 5-fluorouracil for advanced cholangiocarcinoma; currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cadonilimab
• Leucovorin (folinic acid)
• Liposomal irinotecan (liposomal irinotecan)

Snippet

Sponsor: West China Hospital | Conditions: Cholangiocarcinoma | Phase 2 | Status: RECRUITING